Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
TEVA Income Statement
TEVA Balance Sheet
TEVA Cash Flow
Congress Trading

Recent trades of TEVA by members of U.S. Congress

Politician Type Traded
Greg Gianforte House / R Purchase $15,001 - $50,000 Nov. 13, 2020
Donna E. Shalala House / D Sale $1,001 - $15,000 May. 07, 2020
David E. Price House / D Sale $1,001 - $15,000 Jun. 19, 2019
Thad Cochran Senate / R Purchase $15,001 - $50,000 Feb. 12, 2018
Patty Murray Senate / D Sale (Full) $1,001 - $15,000 Jun. 15, 2017
Thad Cochran Senate / R Sale (Full) $1,001 - $15,000 May. 30, 2017
Thad Cochran Senate / R Purchase $1,001 - $15,000 Mar. 17, 2017
Thad Cochran Senate / R Purchase $1,001 - $15,000 Mar. 14, 2017
Cheri Bustos House / D Sale $1,001 - $15,000 Jan. 30, 2017
Angus S. King Jr. Senate / I Sale (Full) $1,001 - $15,000 Oct. 19, 2016
Thad Cochran Senate / R Sale (Full) $1,001 - $15,000 Sep. 29, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 Sep. 12, 2016
Thad Cochran Senate / R Purchase $15,001 - $50,000 Jun. 01, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 May. 11, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 May. 04, 2016
Thad Cochran Senate / R Sale (Full) $1,001 - $15,000 Feb. 02, 2016
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Sep. 11, 2015
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Jul. 27, 2015
K. Michael Conaway House / R Sale $1,001 - $15,000 Feb. 09, 2015
Thomas MacArthur House / R Sale $1,001 - $15,000 Jan. 27, 2015
Thomas MacArthur House / R Purchase $1,001 - $15,000 Jan. 06, 2015
Alan S. Lowenthal House / D Purchase $15,001 - $50,000 Dec. 19, 2014
Alan S. Lowenthal House / D Purchase $15,001 - $50,000 Dec. 12, 2014
K. Michael Conaway House / R Sale $1,001 - $15,000 Mar. 12, 2014
K. Michael Conaway House / R Purchase $1,001 - $15,000 Mar. 06, 2014
TEVA Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
TEVA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
TEVA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by TEVA's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $2,050,000 Apr 20, 2022 Issue: Health Issues
  • $80,000 Apr 20, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Pharmacy Medicare/Medicaid Health Issues
  • $80,000 Apr 11, 2022 Issue: Pharmacy Health Issues
  • $60,000 Jan 24, 2022 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jan 20, 2022 Issue: Health Issues
  • $600,000 Jan 20, 2022 Issue: HEALTH ISSUES
  • $80,000 Jan 13, 2022 Issue: Pharmacy Health Issues
  • $700,000 Oct 25, 2021 Issue: HEALTH ISSUES
  • $810,000 Oct 25, 2021 Issue: HEALTH ISSUES
  • $60,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $80,000 Oct 18, 2021 Issue: Health Issues
  • $80,000 Oct 11, 2021 Issue: Pharmacy Health Issues
  • $80,000 Jul 19, 2021 Issue: Health Issues
  • $50,000 Jul 16, 2021 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jul 12, 2021 Issue: Pharmacy Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $1,820,000 Apr 20, 2021 Issue: HEALTH ISSUES
  • $30,000 Apr 12, 2021 Issue: None
  • $80,000 Apr 12, 2021 Issue: Pharmacy Health Issues
  • $50,000 Jan 21, 2021 Issue: Health Issues
  • $610,000 Jan 21, 2021 Issue: HEALTH ISSUES
  • $80,000 Jan 14, 2021 Issue: Pharmacy Health Issues
  • $80,000 Jan 13, 2021 Issue: Health Issues Pharmacy
  • $40,000 Oct 20, 2020 Issue: Health Issues
  • $500,000 Oct 19, 2020 Issue: HEALTH ISSUES
  • $80,000 Oct 15, 2020 Issue: Pharmacy Health Issues
  • $80,000 Oct 12, 2020 Issue: Health Issues Pharmacy
  • $580,000 Jul 16, 2020 Issue: None
  • $80,000 Jul 13, 2020 Issue: Pharmacy Health Issues
  • $30,000 Jul 07, 2020 Issue: Pharmacy Health Issues
  • $430,000 Apr 20, 2020 Issue: None
  • $80,000 Apr 14, 2020 Issue: Pharmacy Health Issues
  • $30,000 Apr 07, 2020 Issue: Pharmacy Health Issues
  • $410,000 Jan 21, 2020 Issue: None
  • $75,000 Jul 11, 2019 Issue: Pharmacy Health Issues
  • $30,000 Jul 05, 2019 Issue: Medicare/Medicaid Health Issues Pharmacy
  • $740,000 Jun 25, 2019 Issue: Health Issues Trade (domestic/foreign)
  • $30,000 Apr 09, 2019 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $700,000 Jan 21, 2019 Issue: Health Issues
  • $1,130,000 Jul 20, 2018 Issue: Health Issues
  • $90,000 Apr 30, 2018 Issue: Pharmacy
  • $480,000 Apr 20, 2018 Issue: Health Issues
  • $20,000 Apr 20, 2018 Issue: Pharmacy Medicare/Medicaid Health Issues
  • $10,000 Apr 19, 2018 Issue: Health Issues Alcohol and Drug Abuse
  • $40,000 Mar 21, 2018 Issue: None
  • $50,000 Feb 08, 2018 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jan 22, 2018 Issue: Health Issues Alcohol and Drug Abuse
  • $880,000 Jan 22, 2018 Issue: Health Issues Taxation/Internal Revenue Code
  • $90,000 Jan 21, 2018 Issue: Pharmacy
  • $60,000 Jan 18, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Pharmacy
  • $50,000 Oct 27, 2017 Issue: Health Issues Medicare/Medicaid
  • $105,000 Oct 23, 2017 Issue: Pharmacy
  • $1,200,000 Oct 19, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $60,000 Oct 19, 2017 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $40,000 Oct 19, 2017 Issue: Alcohol and Drug Abuse Health Issues
  • $50,000 Aug 08, 2017 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jul 20, 2017 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Government Issues Medicare/Medicaid
  • $840,000 Jul 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $40,000 Jul 19, 2017 Issue: Alcohol and Drug Abuse Health Issues
  • $50,000 May 08, 2017 Issue: Medicare/Medicaid Health Issues
  • $40,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $2,670,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $105,000 Apr 20, 2017 Issue: Pharmacy
  • $50,000 Apr 19, 2017 Issue: Alcohol and Drug Abuse Health Issues
  • $1,170,000 Jan 31, 2017 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $30,000 Jan 27, 2017 Issue: Pharmacy
  • $60,000 Jan 19, 2017 Issue: Health Issues Alcohol and Drug Abuse
  • $50,000 Jan 18, 2017 Issue: Medicare/Medicaid Health Issues
  • $105,000 Jan 17, 2017 Issue: Pharmacy
  • $30,000 Feb 09, 2016 Issue: Pharmacy
  • $50,000 Feb 03, 2016 Issue: Health Issues
  • $45,000 Jan 28, 2016 Issue: Pharmacy
  • $45,000 Jan 28, 2016 Issue: Pharmacy
  • $105,000 Jan 20, 2016 Issue: Pharmacy
  • $60,000 Jan 20, 2016 Issue: Health Issues Labor Issues/Antitrust/Workplace Alcohol and Drug Abuse
  • $900,000 Jan 20, 2016 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
  • $105,000 Oct 21, 2015 Issue: Pharmacy
  • $60,000 Oct 20, 2015 Issue: Labor Issues/Antitrust/Workplace Alcohol and Drug Abuse Health Issues
  • $50,000 Oct 20, 2015 Issue: Health Issues
  • $990,000 Oct 19, 2015 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $45,000 Jul 23, 2015 Issue: Pharmacy
  • $60,000 Jul 20, 2015 Issue: Alcohol and Drug Abuse Health Issues
  • $980,000 Jul 16, 2015 Issue: Pharmacy Trade (domestic/foreign)
  • $105,000 Jul 16, 2015 Issue: Pharmacy
  • $50,000 Jul 16, 2015 Issue: Health Issues
  • $10,000 Jul 13, 2015 Issue: Pharmacy
  • $45,000 Apr 27, 2015 Issue: Pharmacy
  • $50,000 Apr 20, 2015 Issue: Health Issues
  • $60,000 Apr 20, 2015 Issue: Alcohol and Drug Abuse Health Issues
  • $105,000 Apr 20, 2015 Issue: Pharmacy
  • $1,200,000 Apr 19, 2015 Issue: Trade (domestic/foreign) Pharmacy
  • $890,000 Jan 20, 2015 Issue: Pharmacy Trade (domestic/foreign)
  • $880,000 Oct 20, 2014 Issue: Pharmacy Trade (domestic/foreign)
  • $870,000 Jul 21, 2014 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $1,160,000 Apr 18, 2014 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $800,000 Jan 17, 2014 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $810,000 Oct 21, 2013 Issue: Pharmacy Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign)
  • $820,000 Jul 22, 2013 Issue: Tariff (miscellaneous tariff bills) Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Medical injection device packaging May. 09, 2023
  • Patent Title: S1p3 antagonists Oct. 18, 2022
  • Patent Title: Injector pen Nov. 23, 2021
  • Patent Title: Medroxyprogesterone acetate injectable compositions and methods of use Oct. 05, 2021
  • Patent Title: Re-useable injector device for syringe Mar. 19, 2019
  • Patent Title: Analogs of pridopidine, their preparation and use Nov. 20, 2018
  • Patent Title: Re-useable injector device for syringe Sep. 11, 2018
  • Patent Title: Injector pen Aug. 28, 2018
  • Patent Title: S1p3 antagonists Apr. 24, 2018
  • Patent Title: Re-useable injector device for syringe Nov. 28, 2017
  • Patent Title: Process for manufacturing glatiramer acetate product Sep. 19, 2017
  • Patent Title: Process for manufacturing glatiramer acetate product Jul. 18, 2017
  • Patent Title: Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis Jun. 27, 2017
  • Patent Title: Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status May. 30, 2017
  • Patent Title: Dose counter and recording method Apr. 18, 2017
  • Patent Title: Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate Apr. 18, 2017
  • Patent Title: Biomarkers predictive for clinical response for glatiramer acetate Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory appartus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Treatment of bdnf-related disorders using laquinimod Mar. 07, 2017
  • Patent Title: Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate Nov. 22, 2016
  • Patent Title: Formulations of albu-bche, preparation and uses thereof Aug. 09, 2016
  • Patent Title: Formulations of 6-mercaptopurine Jun. 28, 2016
  • Patent Title: R(+)-n-formyl-propargyl-aminoindan May. 24, 2016
  • Patent Title: Stable laquinimod preparations May. 17, 2016
  • Patent Title: R(+)-n-methyl-propargyl-aminoindan May. 17, 2016
  • Patent Title: Parenteral formulations of rasagiline Apr. 12, 2016
  • Patent Title: N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof Mar. 15, 2016
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of TEVA in WallStreetBets Daily Discussion

TEVA News

Recent insights relating to TEVA

CNBC Recommendations

Recent picks made for TEVA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TEVA

TEVA Top Shareholders
Shareholder
Shares Held
TEVA Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

TEVA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view TEVA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top